Tranexamic acid for traumatic brain injury Reply (2020)
Attributed to:
The CRASH-3 Trial: Tranexamic acid for the treatment of significant traumatic brain injury.
funded by
GCRF
Abstract
No abstract provided
Bibliographic Information
Type: Journal Article/Review
Volume: 396
Parent Publication: LANCET
Issue: 10245
ISSN: 0140-6736